European Union

GSK has achieved a significant milestone by securing the first approval for a vaccine against respiratory syncytial virus (RSV) in the European Union

GSK Secures First Approval for RSV Vaccine in EU

SG Tylor

The European Commission has given the green light for GSK’s Arexvy to be used in older adults aged 60 or ...